Factors associated with the implementation of the 5As model of smoking cessation support during pregnancy: A scoping review
Tobacco Induced Diseases · 30.08.2023 · 21 (August) · 1-8
DOI: 10.18332/tid/169623 ↗Kurz gefasst
Scoping Review in der Zeitschrift Tobacco Induced Diseases, online erschienen am 30.08.2023. Verfasst von Adrianna Burtin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Methodology and Innovation in Prevention, Bordeaux University Hospital, Bordeaux, France. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Methodology and Innovation in Prevention, Bordeaux University Hospital, Bordeaux, France.
- Inserm UMR 1219-Bordeaux Population Health, University of Bordeaux, Bordeaux, France.
Zitieren
APA
Burtin, A., Clet, E., Stevens, N., Kervran, C., Frevol, M., Ratel, R., Moysan, P., Alla, F., & 5A-QUIT-N group (2023). Factors associated with the implementation of the 5As model of smoking cessation support during pregnancy: A scoping review. Tobacco Induced Diseases, 21(August), 1-8. https://doi.org/10.18332/tid/169623
Vancouver
Burtin A, Clet E, Stevens N, Kervran C, Frevol M, Ratel R, et al. Factors associated with the implementation of the 5As model of smoking cessation support during pregnancy: A scoping review. Tobacco Induced Diseases. 2023;21(August):1-8. doi:10.18332/tid/169623
BibTeX
@article{Burtin2023,
author = {Burtin, Adrianna and Clet, Estelle and Stevens, Nolwenn and Kervran, Charlotte and Frevol, Manon and Ratel, Rébecca and Moysan, Perrine and Alla, François and 5A-QUIT-N group, 5A-QUIT-N group},
title = {Factors associated with the implementation of the 5As model of smoking cessation support during pregnancy: A scoping review},
journal = {Tobacco Induced Diseases},
year = {2023},
volume = {21},
number = {August},
pages = {1--8},
doi = {10.18332/tid/169623}
}
EUVIMED